Clinical Trial Detail

NCT ID NCT02232516
Title Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Northwestern University
Indications

angioimmunoblastic T-cell lymphoma

anaplastic large cell lymphoma

mature T-cell and NK-cell lymphoma

mycosis fungoides

peripheral T-cell lymphoma

Therapies

Lenalidomide + Romidepsin

Age Groups: adult senior

Additional content available in CKB BOOST